企業プロフィール · Healthcare

Intuitive Surgical Inc

ISRG · 米国株
取引所
米国株
国 / 地域
USA
上場日
2000年6月13日
従業員数
17,021
公式サイト
www.intuitive.com
現在値
$356.83
リアルタイム · 2026年7月27日
ベイリー成長スコア
52/100
標準
本源的価値 · 3 段階レンジ 現在値 $356.83 リアルタイム · 妥当な本源的価値レンジ内

総合バリュエーションレンジ · 保守的 $220–$300 / 妥当 $300–$380 / 楽観的 $380–$430。$356.83 時点で 妥当な本源的価値レンジ内。

レポート公開時 $439.8(2026年5月22日)

時価総額$1209.19億
売上高(TTM)$110.34億
EBITDA$41.81億
純利益率28.45%
ROE17.42%
PER (TTM)38.01
予想PER31.25
PEG1.65
EPS$8.88
52週レンジ$328.57 – $603.88
アナリスト目標株価$484.40
アナリスト評価4.0 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

沿革

Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California. It completed its IPO on June 13, 2000. The company commercialized the da Vinci Surgical System for minimally invasive surgery and later extended beyond surgery with the Ion endoluminal system, which enables minimally invasive lung biopsies. It is currently rolling out its next-generation da Vinci 5 platform globally.

業界での地位

Intuitive Surgical is a Healthcare-sector company in Medical Instruments & Supplies and the leader in robotic-assisted surgery. In 2025 total revenue was USD 10.065B, split into instruments & accessories USD 6.019B, systems USD 2.474B, and service USD 1.572B. Its da Vinci installed base reached about 11,106 systems at the end of 2025 (about 11,395 by 2026Q1), with about 995 Ion systems installed. Named competitors include Johnson & Johnson, Medtronic, CMR Surgical, MicroPort MedBot, and Karl Storz. The company has 17,021 employees, over 5,600 active patents, and spent USD 1.312B on R&D in 2025.

この銘柄のレポートはお使いの言語でまだありません。